Safecon Lifesciences
Favipiravir (400mg)
Fevisafe 400 Tablet is an antiviral medicine used for the treatment of mild to moderate coronavirus disease (COVID-19) in adults.
Tablet
Fevisafe 400 Tablet is an antiviral medicine used for the treatment of mild to moderate coronavirus disease (COVID-19) in adults. It stops the virus from multiplying and therefore, decreases the viral load in the body.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Fevisafe 400 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Increased uric acid levels in blood Diarrhea Decreased white blood cell count (neutrophils) Increased liver enzymes
It is not known whether it is safe to consume alcohol with Fevisafe 400 Tablet. Please consult your doctor.
Fevisafe 400 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Fevisafe 400 Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Fevisafe 400 Tablet is an antiviral medicine. It stops the SARS-CoV-2 virus from multiplying. By doing so, it decreases viral load in the body, restricts the spread of infection and helps in speeding up the recovery process.
Inform your doctor if you have gout, uric acid, liver or kidney disease. Fevisafe 400 Tablet should be administered with care to elderly patients by monitoring their general conditions. Seek immediate medical attention if you see signs of allergic reactions like red or blistering rash, difficulty swallowing or breathing, swelling of the eyelids, lips, face, throat or tongue. It is advisable to use contraceptive methods while taking Fevisafe 400 Tablet and for 7 days after the completion of the treatment. Let your doctor know if you are pregnant or breastfeeding.
Fevisafe 400 Tablet is an antiviral medication used to manage mild to moderate Covid-19 infections.
Fevisafe 400 Tablet is most effective when used early in the treatment of Covid-19 infection, particularly in mildly infected individuals. Delaying treatment can prolong recovery and worsen symptoms. Consult your doctor immediately if you test positive for Covid-19.
Fevisafe 400 Tablet is contraindicated in patients with a known allergy to the medication or its ingredients, severe kidney or liver disease, abnormal uric acid levels, or gout. Additionally, it is not recommended for children, pregnant or breastfeeding women, or individuals with compromised organ functions. Consult your doctor before taking Fevisafe 400 Tablet if you have any underlying medical conditions or are planning a pregnancy.
Fevisafe 400 Tablet should be taken as directed by your doctor. The recommended dose is 1,800 mg twice daily on day 1, followed by 800 mg twice daily up to day 14. Do not self-medicate or adjust your dosage without consulting your doctor.
Fevisafe 400 Tablet should be used with caution in the elderly, with regular monitoring of their condition. It is not recommended for children, as it may cause serious side effects. Consult your doctor before taking Fevisafe 400 Tablet if you are an elderly or pediatric patient.
No, Fevisafe 400 Tablet is not recommended for pregnant or breastfeeding women, as its use may cause harm to the baby. Consult your doctor if you are planning a pregnancy, are pregnant, or are breastfeeding and test positive for Covid-19.
Fevisafe 400 Tablet inhibits the replication of the Covid-19 virus, reducing the amount of virus in the body and promoting faster recovery.
Fevisafe 400 Tablet should be stored at a temperature not exceeding 30 degrees Celsius and kept out of the reach of children.
Yes, Fevisafe 400 Tablet may be used in patients with comorbidities such as diabetes and hypertension, under medical supervision. Follow your doctor's instructions carefully to ensure safe and effective treatment.